Globus Medical, Inc. (GMED) |
| 92.98 2.56 (2.83%) 04-13 16:00 |
| Open: | 89.69 |
| High: | 93.23 |
| Low: | 89.47 |
| Volume: | 1,050,022 |
| Market Cap: | 12,576(M) |
| PE Ratio: | 23.72 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 109.62 |
| Resistance 1: | 93.85 |
| Pivot price: | 88.12 |
| Support 1: | 86.53 |
| Support 2: | 82.01 |
| 52w High: | 101.4 |
| 52w Low: | 51.79 |
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| EPS | 3.920 |
| Book Value | 33.860 |
| PEG Ratio | 0.00 |
| Gross Profit | 14.787 |
| Profit Margin (%) | 18.30 |
| Operating Margin (%) | 24.38 |
| Return on Assets (ttm) | 7.1 |
| Return on Equity (ttm) | 12.3 |
Mon, 13 Apr 2026
Will Analyst Upgrades and Earnings Revisions Change Globus Medical's (GMED) Narrative? - Sahm
Sun, 12 Apr 2026
Cambiar Investors Reduces Stake in Globus Medical - National Today
Fri, 10 Apr 2026
Globus Medical, Inc. Class A Common Stock (NY: GMED - The Chronicle-Journal
Fri, 10 Apr 2026
How Investors Are Reacting To Globus Medical (GMED) Zacks Rank Upgrade On Higher Earnings Estimates - Yahoo Finance
Fri, 10 Apr 2026
Is This the Right Time to Add Globus Medical Stock to Your Portfolio? - Yahoo Finance
Fri, 10 Apr 2026
Is It Too Late To Consider Globus Medical (GMED) After Its Strong Share Price Run? - Sahm
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |